GB
GT Biopharma, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$7.8Msold at filing
Total offering$39M$31.2M still open
Investors in the raise9count reported to the SEC
FiledSep 29, 2026first sale Sep 14, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Charles J. CasamentoDirector
Alan UrbanExecutive Officer
David C. Mun-GavinDirector
Michael BreenExecutive Officer, Director
Hilary J. KramerDirector
Executive officers, directors and promoters as listed on the Form D.